Modi Naturals appoints Ankita Singal as independent director at subsidiary
Modi Naturals Limited appointed Ankita Singal as an independent director at its subsidiary Modi Biotech Private Limited on July 30, 2026. The appointment follows approval at the subsidiary's AGM and complies with SEBI Listing Regulations. Singal brings two decades of experience in finance and business management to the board.

*this image is generated using AI for illustrative purposes only.
Modi Naturals Limited has appointed Ankita Singal as a Non-Executive Independent Women Director at its unlisted material subsidiary, Modi Biotech Private Limited. The appointment was approved by the members of Modi Biotech at their fifth Annual General Meeting held on July 30, 2026, and becomes effective on the same date. This move strengthens the governance framework of the subsidiary, ensuring compliance with regulatory requirements for independent representation on the board.
The disclosure was made in compliance with Regulation 24 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the company adhered to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, regarding disclosures related to changes in directorship. Rajan Kumar Singh, Company Secretary & Compliance Officer of Modi Naturals Limited, signed the intimation letter submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE).
Appointment Details
The key details of the appointment are outlined below:
| Particulars | Details |
|---|---|
| Appointee | Ankita Singal (DIN: 01633449) |
| Role | Non-Executive Independent Women Director |
| Entity | Modi Biotech Private Limited |
| Effective Date | July 30, 2026 |
| Approval Forum | 5th Annual General Meeting of Modi Biotech |
Profile and Compliance
Ankita Singal holds a Bachelor of Commerce (Honours) degree from Lady Shriram College for Women, Delhi University, and a Master in Business Administration from Infinity Business School. She possesses approximately 20 years of experience across finance, marketing, and general business management.
As per the disclosure requirements under BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018, and NSE Circular No. NSE/CML/2018/02 dated June 20, 2018, Singal is not related to any existing directors of Modi Naturals Limited. Furthermore, she is not debarred from holding the office of a Director by virtue of any order issued by the Ministry of Corporate Affairs (MCA), SEBI, or any other statutory authority.
Historical Stock Returns for Modi Naturals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.41% | -3.80% | -5.36% | +15.70% | +4.68% | +4.68% |
How might Ankita Singal's 20 years of experience in finance and marketing influence Modi Biotech's strategic growth plans for its unlisted operations?
Does this appointment signal a broader initiative by Modi Naturals to enhance corporate governance across its subsidiary portfolio ahead of potential future listing requirements?
What specific regulatory or operational challenges within the biotech sector is Modi Biotech aiming to address by strengthening its independent board representation?


































